Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm

Running, not enrolling · Not applicable

Conditions studied: Intracranial Aneurysms

In brief

The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms

Key facts

Study ID

NCT06411418

Run by

Jacobs institute

People needed

10

Starts

2023-09-01

Expected to finish

2026-12-30

Last updated by the study team

2026-03-10

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments.

You may not qualify if…

• Cannot provide consent or legally authorized representative not available to provide consent

Where it is running

• University at Buffalo Neurosurgery — Buffalo, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.